Literature DB >> 9371552

Poliovirus 2C protein determinants of membrane binding and rearrangements in mammalian cells.

N L Teterina1, A E Gorbalenya, D Egger, K Bienz, E Ehrenfeld.   

Abstract

Poliovirus protein 2C is a 329-amino acid-protein that is essential for viral RNA synthesis and may perform multiple functions. In infected cells, it is associated with virus-specific membrane vesicles. Recombinant 2C protein expressed in transfected cells has been shown to associate with and induce rearrangement of the intracellular membrane network. This study was designed to map the determinants of membrane binding and rearrangement in the 2C protein. Computer-assisted analysis of the protein sequence led to a prediction that the protein folds into a structure composed of three domains. Expression plasmids that encode each or combinations of these predicted domains were used to examine the abilities of the partial protein sequences to associate with intracellular membranes and to induce rearrangement of these membranes in HeLa cells. Biochemical fractionation procedures suggested that the N-terminal region of the protein was required for membrane association. Electron microscopic and immunoelectron microscopic observation showed that both the N- and C-terminal regions, but not the central portion, of 2C protein interact with intracellular membranes and induce major changes in their morphology. The central portion, when fused to the N-terminal region, altered the specific membrane architecture induced by the N-terminal region, giving rise to vesicles resembling those observed during poliovirus infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371552      PMCID: PMC230196     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  A workbench for multiple alignment construction and analysis.

Authors:  G D Schuler; S F Altschul; D J Lipman
Journal:  Proteins       Date:  1991

2.  A new superfamily of putative NTP-binding domains encoded by genomes of small DNA and RNA viruses.

Authors:  A E Gorbalenya; E V Koonin; Y I Wolf
Journal:  FEBS Lett       Date:  1990-03-12       Impact factor: 4.124

3.  A conserved NTP-motif in putative helicases.

Authors:  A E Gorbalenya; E V Koonin; A P Donchenko; V M Blinov
Journal:  Nature       Date:  1988-05-05       Impact factor: 49.962

4.  Expression and subcellular localization of poliovirus VPg-precursor protein 3AB in eukaryotic cells: evidence for glycosylation in vitro.

Authors:  U Datta; A Dasgupta
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

5.  Construction of the full local similarity map for two biopolymers.

Authors:  A M Leontovich; L I Brodsky; A E Gorbalenya
Journal:  Biosystems       Date:  1993       Impact factor: 1.973

6.  Prediction of protein secondary structure at better than 70% accuracy.

Authors:  B Rost; C Sander
Journal:  J Mol Biol       Date:  1993-07-20       Impact factor: 5.469

7.  Biochemical studies on poliovirus polypeptide 2C: evidence for ATPase activity.

Authors:  C Mirzayan; E Wimmer
Journal:  Virology       Date:  1994-02-15       Impact factor: 3.616

8.  Intracellular distribution of poliovirus proteins and the induction of virus-specific cytoplasmic structures.

Authors:  K Bienz; D Egger; Y Rasser; W Bossart
Journal:  Virology       Date:  1983-11       Impact factor: 3.616

9.  Cellular origin and ultrastructure of membranes induced during poliovirus infection.

Authors:  A Schlegel; T H Giddings; M S Ladinsky; K Kirkegaard
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

10.  Membrane permeabilization by poliovirus proteins 2B and 2BC.

Authors:  R Aldabe; A Barco; L Carrasco
Journal:  J Biol Chem       Date:  1996-09-20       Impact factor: 5.157

View more
  91 in total

1.  A cysteine-rich motif in poliovirus protein 2C(ATPase) is involved in RNA replication and binds zinc in vitro.

Authors:  T Pfister; K W Jones; E Wimmer
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A.

Authors:  S B Deitz; D A Dodd; S Cooper; P Parham; K Kirkegaard
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

3.  Initiation of poliovirus negative-strand RNA synthesis requires precursor forms of p2 proteins.

Authors:  Christy Jurgens; James B Flanegan
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

4.  Intracellular topology and epitope shielding of poliovirus 3A protein.

Authors:  Sunny S Choe; Karla Kirkegaard
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

5.  Strand-specific RNA synthesis defects in a poliovirus with a mutation in protein 3A.

Authors:  Natalya L Teterina; Mario S Rinaudo; Ellie Ehrenfeld
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

6.  Evolution of poliovirus defective interfering particles expressing Gaussia luciferase.

Authors:  Yutong Song; Aniko V Paul; Eckard Wimmer
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

7.  Development of broad-spectrum enterovirus antivirals based on quinoline scaffold.

Authors:  Rami Musharrafieh; Naoya Kitamura; Yanmei Hu; Jun Wang
Journal:  Bioorg Chem       Date:  2020-06-01       Impact factor: 5.275

8.  T135I substitution in the nonstructural protein 2C enhances foot-and-mouth disease virus replication.

Authors:  Tiangang Yuan; Haiwei Wang; Chen Li; Decheng Yang; Guohui Zhou; Li Yu
Journal:  Virus Genes       Date:  2017-06-20       Impact factor: 2.332

9.  Isolation of enzymatically active replication complexes from feline calicivirus-infected cells.

Authors:  Kim Y Green; Aaron Mory; Mark H Fogg; Andrea Weisberg; Gaël Belliot; Mariam Wagner; Tanaji Mitra; Ellie Ehrenfeld; Craig E Cameron; Stanislav V Sosnovtsev
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Aichi virus leader protein is involved in viral RNA replication and encapsidation.

Authors:  Jun Sasaki; Shigeo Nagashima; Koki Taniguchi
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.